Cargando…
Activation of Latent HIV Using Drug-Loaded Nanoparticles
Antiretroviral therapy is currently only capable of controlling HIV replication rather than completely eradicating virus from patients. This is due in part to the establishment of a latent virus reservoir in resting CD4+ T cells, which persists even in the presence of HAART. It is thought that force...
Autores principales: | Kovochich, Michael, Marsden, Matthew D., Zack, Jerome A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3071729/ https://www.ncbi.nlm.nih.gov/pubmed/21483687 http://dx.doi.org/10.1371/journal.pone.0018270 |
Ejemplares similares
-
Designed, Synthetically Accessible Bryostatin Analogues Potently Induce Activation of Latent HIV Reservoirs in vitro
por: DeChristopher, Brian A., et al.
Publicado: (2012) -
In vivo activation of latent HIV with a synthetic bryostatin analog effects both latent cell "kick" and "kill" in strategy for virus eradication
por: Marsden, Matthew D., et al.
Publicado: (2017) -
Pharmacological Activation of Non-canonical NF-κB Signaling Activates Latent HIV-1 Reservoirs In Vivo
por: Pache, Lars, et al.
Publicado: (2020) -
Secreted factors induced by PKC modulators do not indirectly cause HIV latency reversal
por: Moran, Jose A., et al.
Publicado: (2023) -
Bioengineered Vaults: Self-Assembling Protein Shell–Lipophilic Core Nanoparticles for Drug Delivery
por: Buehler, Daniel C., et al.
Publicado: (2014)